GlassScriptPhysician profile
Maria Carr
NPI 1922666361
$1,017.23
in general payments reported to CMS, 2019-2025
13 companies · $195 in 2025
The $195 reported for 2025 was more than what 80% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.87 · 2022: $85.56 · 2023: $113 · 2024: $556 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $181.27 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $161.24 | 2024 | Aptima |
| Organon LLC | $151.60 | 2021-2023 | Nexplanon |
| Sumitomo Pharma America, INC. | $144.32 | 2024-2025 | Gemtesa, Myfembree |
| Mayne Pharma Commercial LLC | $115.31 | 2024-2025 | |
| Gilead Sciences, INC. | $81.99 | 2021-2023 | |
| Biogen, INC. | $53.69 | 2025 | Zurzuvae |
| Axonics, INC. | $29.97 | 2024 | Axonics |
| Medtronic, INC. | $22.83 | 2024 | Interstim |
| Boston Scientific Corporation | $22.57 | 2025 | Axonics |
| Shield Therapeutics INC | $19.50 | 2024 | |
| Coopersurgical, INC. | $18.67 | 2022 | |
| Merck Sharp & Dohme LLC | $14.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.